Cyclic Citrullinated Peptide Market Trends: Brand Comparison, Technical Pros & Cons, and Application Scope
Published: July 13, 2026 20:36
Author: Anjali Dalton
Abstract: The cyclic citrullinated peptide (CCP) market is driven by its critical role in rheumatoid arthritis diagnostics. Leading brands (e.g., Euroimmun, Inova) show comparable sensitivity ( 80%) but differ in specificity (98% vs. 95%) and synthetic peptide stability. Technical pros include high autoimmune specificity; cons involve batch variability and cost. Applications span ELISA, POCT, and research. Current market trends favor automated, high-throughput assays. Key selection criteria include CE/FDA certification, peptide purity (>95%), and cold-chain logistics. Industry data projects 6.5% CAGR through 2030, with rising demand for citrullinated peptide-based theranostics.